Cancer Causes & Control

, Volume 24, Issue 8, pp 1583–1593

Recommendations for a national agenda to substantially reduce cervical cancer

  • Jennifer S. Smith
  • Noel T. Brewer
  • Debbie Saslow
  • Kenneth Alexander
  • Mildred R. Chernofsky
  • Richard Crosby
  • Libby Derting
  • Leah Devlin
  • Charles J. Dunton
  • Jeffrey Engle
  • Maria Fernandez
  • Mona Fouad
  • Warner Huh
  • Walter Kinney
  • Jennifer Pierce
  • Elena Rios
  • Mitchel C. Rothholz
  • Judith C. Shlay
  • Rivienne Shedd-Steele
  • Sally W. Vernon
  • Joan Walker
  • Theresa Wynn
  • Gregory D. Zimet
  • Baretta R. Casey
Original paper



Prophylactic human papillomavirus (HPV) vaccines and new HPV screening tests, combined with traditional Pap test screening, provide an unprecedented opportunity to greatly reduce cervical cancer in the USA. Despite these advances, thousands of women continue to be diagnosed with and die of this highly preventable disease each year. This paper describes the initiatives and recommendations of national cervical cancer experts toward preventing and possibly eliminating this disease.


In May 2011, Cervical Cancer-Free America, a national initiative, convened a cervical cancer summit in Washington, DC. Over 120 experts from the public and private sector met to develop a national agenda for reducing cervical cancer morbidity and mortality in the USA.


Summit participants evaluated four broad challenges to reducing cervical cancer: (1) low use of HPV vaccines, (2) low use of cervical cancer screening, (3) screening errors, and (4) lack of continuity of care for women diagnosed with cervical cancer. The summit offered 12 concrete recommendations to guide future national and local efforts toward this goal.


Cervical cancer incidence and mortality can be greatly reduced by better deploying existing methods and systems. The challenge lies in ensuring that the array of available prevention options are accessible and utilized by all age-appropriate women—particularly minority and underserved women who are disproportionately affected by this disease. The consensus was that cervical cancer can be greatly reduced and that prevention efforts can lead the way towards a dramatic reduction in this preventable disease in our country.


Cervical cancer prevention Human papillomavirus HPV vaccine HPV test Pap test 

List of symbols


Affordable Care Act of 2010


Advisory Committee on Immunization Practices


American Cancer Society


American Society for Colposcopy and Cervical Pathology


American Society for Clinical Pathology


Cervical Cancer-Free America


Centers for Disease Control and Prevention


Children’s Health Insurance Program


Food and Drug Administration


Family Education Rights and Privacy Act


Federally Qualified Health Centers


Human papillomavirus


National Breast and Cervical Cancer Early Detection Program




University of North Carolina


United States Preventive Services Task Force


Vaccines for Children


  1. 1.
    U.S. Preventive Services Task Force (2012) Screening for cervical cancer: Recommendation statement. Am Fam Physician 86(6):555–559Google Scholar
  2. 2.
    American Cancer Society (2012) Cancer facts and figures; Available at Accessed 22 Feb 2012
  3. 3.
    Schiffman M (2007) Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer 111(3):145–153PubMedCrossRefGoogle Scholar
  4. 4.
    Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al (2003) Epidemiologic classification of human papillomavirus types associated with cancer. N Engl J Med 348:518–527PubMedCrossRefGoogle Scholar
  5. 5.
    Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19PubMedCrossRefGoogle Scholar
  6. 6.
    Cervical cancer free America: Carolina framework. Available at: Accessed 22 Feb 2012
  7. 7.
    Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH et al (2008) Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26(Suppl 10):K29–K41PubMedCrossRefGoogle Scholar
  8. 8.
    ACOG committee on practice bulletins-gynecology (2009) ACOG practice bulletin no. 109: cervical cytology screening. Obstet Gynecol 114(6):1409–1420Google Scholar
  9. 9.
    Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J et al (2012) American cancer society, American Society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer CA. Cancer J Clin 62(3):147–172CrossRefGoogle Scholar
  10. 10.
    US Preventive Services Task Force. Screening for Cervical Cancer. April 2012; Available at: Accessed 20 Sept 2012
  11. 11.
    Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R et al (2007) Human papillomavirus type-distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121(3):621–623PubMedCrossRefGoogle Scholar
  12. 12.
    Centers for disease control and prevention (CDC) (2007) Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). MMWR 56(RR02):1–24Google Scholar
  13. 13.
    Centers for disease control and prevention (CDC) (2010) FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the advisory committee on immunization practices (ACIP). MMWR 59(20):626–629Google Scholar
  14. 14.
    Centers for disease control and prevention (CDC) (2011) Recommendations on the use of quadrivalent human papillomavirus vaccine in males-advisory committee on immunization practices (ACIP). MMWR 60:1705–1708Google Scholar
  15. 15.
    Kaiser family foundation/urban institute. Analysis of the 2010 current population survey, US Bureau of the Census. Available at:
  16. 16.
    Medicare: The Official US Government site for medicare. 2012; Available at: Accessed 12 Nov 2012
  17. 17.
    Kaiser family foundation/urban institute. Analysis of the 2011 current population survey, US Bureau of the census. Available at:
  18. 18.
    Advisory committee on immunization practices (2011) Vaccines for children program: Vaccines to prevent human papillomavirus. 010(11-1)Google Scholar
  19. 19.
    Medicaid/children’s health insurance program (2012) Children’s health insurance program (CHIP); Available at: Accessed 22 Feb 2012
  20. 20.
    Centers for disease control and prevention (2012) National breast and cervical cancer early detection program; Available at: Accessed 12 Nov 2012
  21. 21.
    Office of population affairs, US department of health and human services (2012) Title X family planning. Available at: Accessed 13 Nov 2012
  22. 22.
    Institute of Medicine (2011) Clinical preventive services for women: closing the gaps. The National Academies Press, Washington, DCGoogle Scholar
  23. 23.
    Wakefield, M (2011) Remarks to the first annual cervical cancer-free America forum. First annual cervical cancer-free America ForumGoogle Scholar
  24. 24.
    Centers for disease control and prevention (2011) National and state vaccination coverage among adolescents aged 13–17 Years—United States, 2011. MMWR 61(34):671–677Google Scholar
  25. 25.
    Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L et al (2011) Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 38(3):197–204PubMedCrossRefGoogle Scholar
  26. 26.
    Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R et al (2011) Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine 29(47):8634–8641PubMedCrossRefGoogle Scholar
  27. 27.
    Brewer NT, Fazekas KI (2007) Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45(2–3):107–114PubMedCrossRefGoogle Scholar
  28. 28.
    Immunize Australia program (2009) The National HPV vaccination program register; Available at: Accessed 22 Feb 2012
  29. 29.
    National Services Scotland (2011) HPV immunisation uptake statistics year 3 of the HPV immunisation programme (2010/11); Available at Accessed 23 Feb 2012
  30. 30.
    Smith JS, Brewer NT, Chang Y, Liddon N, Guerry S, Pettigrew E et al (2011) Acceptability of school requirements for human papillomavirus vaccine. Hum Vaccin 7(9):952–957PubMedCrossRefGoogle Scholar
  31. 31.
    Hayes K, Entzel P, Berger W, Caskey R, Shlay J, Stubbs B et al (2013) Early lessons learned from extramural school programs that offer HPV vaccine. J Sch Health 83(2):119–126Google Scholar
  32. 32.
    Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA (2000) Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 88(10):2283–2289PubMedCrossRefGoogle Scholar
  33. 33.
    Kinney W, Sung HY, Kearney KA, Miller M, Sawaya G, Hiatt RA (1998) Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC). Gynecol Oncol 71(3):428–430PubMedCrossRefGoogle Scholar
  34. 34.
    Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K et al (2005) Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 97(9):675–683PubMedCrossRefGoogle Scholar
  35. 35.
    Spence AR, Goggin P, Franco EL (2007) Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 45(2):93–106PubMedCrossRefGoogle Scholar
  36. 36.
    Centers for disease control and prevention (2011) National health interview survey public use data file 2010Google Scholar
  37. 37.
    Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(4):748–757PubMedCrossRefGoogle Scholar
  38. 38.
    Freeman HP WB (2005) Excess cervical cancer mortality: a marker for low access to health care in poor communities. NIH Pub 2005; No. 05-5282Google Scholar
  39. 39.
    Moyer VA (2012) Screening for cervical cancer: US preventive services task force recommendation statement. Ann Intern Med 156(12):880–891PubMedCrossRefGoogle Scholar
  40. 40.
    NIH consensus statement (1996) 14(1):1–38Google Scholar
  41. 41.
    Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D et al (2007) 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197(4):346–355PubMedCrossRefGoogle Scholar
  42. 42.
    Lee JW, Berkowitz Z, Saraiya M (2011) Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among US health care providers. Obstet Gynecol 118(1):4–13PubMedCrossRefGoogle Scholar
  43. 43.
    Akers AY, Newmann SJ, Smith JS (2007) Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 31(3):157–181PubMedCrossRefGoogle Scholar
  44. 44.
    Eggleston KS, Coker AL, Das IP, Cordray ST, Luchok KJ (2007) Understanding barriers for adherence to follow-up care for abnormal pap tests. J Womens Health (Larchmt) 16(3):311–330CrossRefGoogle Scholar
  45. 45. The health care law & you: implementation resources; regulations & guidance. Available at: Accessed 14 Nov 2012
  46. 46.
    Robertson R, Collins SR. Women at risk: why increasing numbers of women are failing to get the health care they need and how the Affordable Care Act will help. Findings from the Commonwealth Fund Biennial Health Insurance Survey of 2010 Issue Brief (Commonw Fund) 2011 May;3:1-24Google Scholar
  47. 47.
    Kaiser family foundation (2012) Implementing the ACA’s medicaid-related health reform provisions after the Supreme Court’s decision; Available at: Accessed 1 Sept 12
  48. 48.
    Congressional budget office (2012) Estimates for the insurance coverage provisions of the Affordable Care Act updated for the recent Supreme Court decision; Available at Accessed 1 Aug 12
  49. 49.
    Sommers BD, Tomasi MR, Swartz K, Epstein AM (2012) Reasons for the wide variation in Medicaid participation rates among states hold lessons for coverage expansion in 2014. Health Aff (Millwood) 31(5):909–919Google Scholar
  50. 50.
    Nell J, Cheal N, Ackermann SP, Bassford TL, Campos-Outcalt D (1992) Breast and cervical cancer screening in minority populations: a model for using lay health educators. J Cancer Edu 7(4):321–326CrossRefGoogle Scholar
  51. 51.
    Swider SM (2002) Outcome effectiveness of community health workers: an integrative literature review. Public Health Nurs 19(1):11–20PubMedCrossRefGoogle Scholar
  52. 52.
    Community preventive services task force (2011) Guide to community preventive services (Community Guide). 2011; Available at: Accessed 5/6/2012
  53. 53.
    Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD (2011) Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine 29(5):890–895PubMedCrossRefGoogle Scholar
  54. 54.
    Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M et al (2010) A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med 7(5):e1000270PubMedCrossRefGoogle Scholar
  55. 55.
    Sheridan A, White J (2011) Annual HPV vaccine coverage in England in 2009/2010; Available at: Accessed 23 Feb 2012
  56. 56.
    Reiter PL, McRee AL, Pepper JK, Chantala K, Brewer NT (2012) Improving human papillomavirus vaccine delivery: a national study of parents and their adolescent sons. J Adolesc Health 51(1):32–37Google Scholar
  57. 57.
    Middleman AB, Rosenthal SL, Rickert LI, Neinstein L, Fishbein DB, D’Angelo L (2006) Adolescent immunizations: a position paper of the society for adolescent medicine. J Adolsec Health 38(38):321–327CrossRefGoogle Scholar
  58. 58.
    Fritts M (2012) Pharmacists can help you and your family stay healthy and avoid illness; Available at: Accessed 10 Jan 2012
  59. 59.
    Rothholz M (2011) American pharmacists association. Presentation at the first annual cervical cancer-free America forum. 5 May 2011Google Scholar
  60. 60.
    Briss PA, Rodewald LE, Hinman AR,  Shefer AM,  Strikas RA, Bernier RR et al. (2000) Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The task force on community preventive services. Am J Prev Med 18(1Suppl):97–140Google Scholar
  61. 61.
    Jacobsen VJ, Szilagyi P (2005) Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev (3):CD003941Google Scholar
  62. 62.
    Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, Daley MF, Dickinson LM (2012) Effectiveness and cost of immunization recall at school-based health centers. Pediatrics 129(6):e1446–52Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Jennifer S. Smith
    • 1
  • Noel T. Brewer
    • 18
  • Debbie Saslow
    • 2
  • Kenneth Alexander
    • 3
  • Mildred R. Chernofsky
    • 4
  • Richard Crosby
    • 5
  • Libby Derting
    • 6
  • Leah Devlin
    • 19
  • Charles J. Dunton
    • 7
  • Jeffrey Engle
    • 8
  • Maria Fernandez
    • 9
  • Mona Fouad
    • 10
  • Warner Huh
    • 10
  • Walter Kinney
    • 11
  • Jennifer Pierce
    • 12
  • Elena Rios
    • 13
  • Mitchel C. Rothholz
    • 14
  • Judith C. Shlay
    • 15
  • Rivienne Shedd-Steele
    • 16
  • Sally W. Vernon
    • 9
  • Joan Walker
    • 17
  • Theresa Wynn
    • 10
  • Gregory D. Zimet
    • 16
  • Baretta R. Casey
    • 5
  1. 1.Department of EpidemiologyUNC Gillings School of Global Public HealthChapel HillUSA
  2. 2.American Cancer SocietyAtlantaUSA
  3. 3.Pediatric Infectious DiseasesUniversity of ChicagoChicagoUSA
  4. 4.Sibley Center for Gynecologic Oncology and Advanced Pelvic SurgeryWashingtonUSA
  5. 5.University of Kentucky College of Public HealthLexingtonUSA
  6. 6.Women in GovernmentWashingtonUSA
  7. 7.Division of Gynecologic OncologyLankenau HospitalWynnewoodUSA
  8. 8.North Carolina Department of Health and Human ServicesRaleighUSA
  9. 9.The University of Texas School of Public HealthHoustonUSA
  10. 10.School of MedicineUniversity of Alabama at BirminghamBirminghamUSA
  11. 11.The Permanente Medical GroupSacramentoUSA
  12. 12.Medical University of South CarolinaCharlestonUSA
  13. 13.National Hispanic Medical AssociationWashingtonUSA
  14. 14.American Pharmacists AssociationWashingtonUSA
  15. 15.Denver Public HealthDenver Health and Hospital AuthorityDenverUSA
  16. 16.School of MedicineIndianapolisUSA
  17. 17.University of Oklahoma Health Sciences CenterOklahoma CityUSA
  18. 18.Department of Health BehaviorUNC Gillings School of Global Public HealthChapel HillUSA
  19. 19.Department of Health Policy and ManagementUNC Gillings School of Global Public HealthChapel HillUSA

Personalised recommendations